Distribution of medicines to the Developing World is a passion of mine, but people need to understand all the reasons for it not working as it should. In the area of infection I actually think that efficient distribution of currently available drugs is more important than developing new ones.
Your point about Universities is also interesting. They can innovate in a way that Pharma struggle to. In the UK at least, there is not strong enough partnering between Industry and Academia to develop innovation, hence the development of the AHSCs. Lots more to be done there.